Complement biology for hematologists

被引:16
作者
Duval, Anna [1 ,2 ]
Fremeaux-Bacchi, Veronique [1 ,3 ]
机构
[1] Ctr Rech Cordeliers, Inserm, UMR S1138, Paris, France
[2] Univ Hosp Strasbourg, Dept Nephrol Dialysis & Transplantat, Strasbourg, France
[3] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Immunol, Paris, France
关键词
PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; HEMOLYTIC-UREMIC SYNDROME; SICKLE-CELL-DISEASE; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; FACTOR-H; IMMUNE THROMBOCYTOPENIA; INHIBITOR ECULIZUMAB; TRANSFUSION REACTION; TERMINAL COMPLEMENT;
D O I
10.1002/ajh.26855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The complement system is part of the innate immunity. An increased activation or a loss of the regulation of this fine-tuned cascade is involved in a variety of hematological diseases. During the last decade, anti-C5 therapies have revolutionized the management and prognosis of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic and uremic syndrome (aHUS). The availability of a rapidly growing number of innovative complement inhibitors has opened new therapeutic perspectives for several other hematological disorders in which the complement is involved at different degrees. This review focuses on complement biology and its mechanisms of activation in hematological diseases.
引用
收藏
页码:S5 / S19
页数:15
相关论文
共 148 条
[21]   Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration [J].
Cannas, Giovanna ;
Dubreuil, Lea ;
Fichez, Axel ;
Gerfaud-Valentin, Mathieu ;
Debard, Anne-Lise ;
Hot, Arnaud .
AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
[22]   Carfilzomib-induced haemolytic and uremic syndrome: Favorable outcome with eculizumab [J].
Casiez, Catherine ;
Pica, Gian Matteo ;
Bally, Stephane .
NEPHROLOGIE & THERAPEUTIQUE, 2020, 16 (04) :221-224
[23]   Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura [J].
Chapin, John ;
Weksler, Babette ;
Magro, Cynthia ;
Laurence, Jeffrey .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (06) :772-774
[24]   Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications [J].
Chaturvedi, Shruti ;
Braunstein, Evan M. ;
Brodsky, Robert A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (03) :607-616
[25]   Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS [J].
Chaturvedi, Shruti ;
Braunstein, Evan M. ;
Yuan, Xuan ;
Yu, Jia ;
Alexander, Alice ;
Chen, Hang ;
Gavriilaki, Eleni ;
Alluri, Ravi ;
Streiff, Michael B. ;
Petri, Michelle ;
Crowther, Mark A. ;
McCrae, Keith R. ;
Brodsky, Robert A. .
BLOOD, 2020, 135 (04) :239-251
[26]   Complement in the Pathophysiology of the Antiphospholipid Syndrome [J].
Chaturvedi, Shruti ;
Brodsky, Robert A. ;
McCrae, Keith R. .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[27]   Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features [J].
Cheloff, Abraham Z. ;
Kuter, David J. ;
Al-Samkari, Hanny .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (05) :807-812
[28]   Dysregulation of complement system in HELLP syndrome [J].
Chen, Shi ;
Li, Zheng ;
He, Yingdong ;
Chen, Qian .
HYPERTENSION IN PREGNANCY, 2021, 40 (04) :303-311
[29]   Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab [J].
Chonat, Satheesh ;
Chandrakasan, Shanmuganathan ;
Kalinyak, Karen Ann ;
Ingala, David ;
Gruppo, Ralph ;
Kalfa, Theodosia A. .
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (04) :744-747
[30]   Tissue-Specific Host Recognition by Complement Factor H Is Mediated by Differential Activities of Its Glycosaminoglycan-Binding Regions [J].
Clark, Simon J. ;
Ridge, Liam A. ;
Herbert, Andrew P. ;
Hakobyan, Svetlana ;
Mulloy, Barbara ;
Lennon, Rachel ;
Wuerzner, Reinhard ;
Morgan, B. Paul ;
Uhrin, Dusan ;
Bishop, Paul N. ;
Day, Anthony J. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (05) :2049-2057